found no difference in the effect of PD-L1 knockdown or overexpression on the efficacy of ICB therapy in colon, ovarian, melanoma, and lung cancer cell mouse models; however, they observed that functionally high expression of PD-L1 on macrophages was correlated with the efficacy of ICB and prognosis of patients (59). This evidence concerns the gene CD274 and lung carcinoma.